United Kingdom

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

26 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Heidenheim Bak, Hanne 

Ms. Hanne Heidenheim Bak has been appointed Director, Employee Representative at Zealand Pharma A/S, effective as of April 19, 2016. She previously held that position at the Company from April 17, 2012 to April 29, 2014. She is Senior Project Director, GI, External Relations and Collaborations and she holds M.Sc. (Pharm) from the Danish University of Pharmaceutical Sciences. Prior to joining Zealand in 2006, Hanne H. Bak worked 8 years as Project Manager of late-phase development programs at H. Lundbeck A/S, followed by 9 years as Executive Director at the Lundbeck Institute.

Basic Compensation

Total Annual Compensation, DKK 300,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 300,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --